Scion Pharmaceuticals
Biotechnology company.
Launch date
Market cap
-
Enterprise valuation
AUD25—37m (Dealroom.co estimates Nov 2001.)
Boston Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$4.0m | Series A | ||
$17.5m | Series B | ||
| Total Funding | AUD33.2m | ||
Related Content
Recent News about Scion Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.